Wen Tsung Huang

Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy

Shiang Jiin Leaw, Chia Jui Yen, Wen Tsung Huang et al. · Annals of Hematology · 2004 · 78 citations

Lymphoid Neoplasia, Hepatitis B Reactivation, Hepatology +11

Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type.

Wen Tsung Huang, Kun Chao Chang, G. C. Huang et al. · PubMed · 2005 · 39 citations

Preliminary safety and efficacy results from phase 1 studies of DZD9008 in NSCLC patients with EGFR Exon20 insertion mutations.

James Chih‐Hsin Yang, Mengzhao Wang, Paul Mitchell et al. · Journal of Clinical Oncology · 2021 · 36 citations

Pathology, Preliminary Safety, Pharmacotherapy +21

<p>Hypertension as a predictive biomarker in patients with advanced non-small-cell lung cancer treated with apatinib</p>

Shencun Fang, Wen Tsung Huang, Ying‐Ming Zhang et al. · OncoTargets and Therapy · 2019 · 22 citations · Full text

Advanced Nsclc, Prognostic Biomarkers, Hypertension +14

Successful initial treatment with weekly 24-hour infusion of 5-fluorouracil and leucovorin in a rectal cancer patient with acute disseminated intravascular coagulation.

Wen Tsung Huang, Kung Chao Chang, Shan Yan et al. · PubMed · 2005 · 10 citations

Surgical Oncology, Pathology, Intravascular Coagulation +18